Sales Reps Slap Forest Labs With $100M Sex Bias Case

Law360, New York (July 5, 2012, 3:40 PM EDT) -- Four ex-sales representatives filed a $100 million putative class action against drug maker Forest Laboratories Inc. in New York on Thursday, claiming that female employees — particularly those who are pregnant or have children — get short shrift on compensation and promotions, attorneys for the plaintiffs said.

The suit, which targets Forest Laboratories and subsidiary Forest Pharmaceuticals Inc., is a proposed class action under Title VII and collective action under the Equal Pay Act. The complaint also includes non-class claims for sexual harassment, retaliation and violations...
To view the full article, register now.